Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

Mycenax Biotech Inc 4726 Financial and Strategic SWOT Analysis Review Updated 13012017 Prices from USD $300

$
0
0
SummaryMycenax Biotech Inc Mycenax develops and manufactures pharmaceutical formulations. The company's pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis glioblastoma asthma adult crohn's Disease and br...

Viewing all articles
Browse latest Browse all 2985

Trending Articles